{"id":64636,"date":"2026-05-07T14:25:24","date_gmt":"2026-05-07T06:25:24","guid":{"rendered":"https:\/\/flcube.com\/?p=64636"},"modified":"2026-05-07T14:25:25","modified_gmt":"2026-05-07T06:25:25","slug":"eli-lilly-commits-additional-4-5-billion-to-indiana-manufacturing-genetic-medicine-facility-launches-as-total-investment-exceeds-21-billion","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=64636","title":{"rendered":"Eli Lilly Commits Additional $4.5 Billion to Indiana Manufacturing \u2013 Genetic Medicine Facility Launches as Total Investment Exceeds $21 Billion"},"content":{"rendered":"\n<p><strong>Eli Lilly and Company<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/quote\/LLY:NYSE\">NYSE: LLY<\/a>) announced on <strong>May 6, 2026<\/strong>, an <strong>additional USD 4.5 billion investment<\/strong> across two of its three <strong>Lebanon, Indiana sites<\/strong>, bringing the company&#8217;s <strong>total capital expansion commitments in Indiana since 2020 to more than USD 21 billion<\/strong>. The investment is driven by <strong>Lilly&#8217;s evolving pipeline<\/strong> and <strong>anticipated demand for its medicines<\/strong>, including next-generation genetic therapies targeting disease at the molecular level.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-investment-breakdown-amp-strategic-allocation\">Investment Breakdown &amp; Strategic Allocation<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Facility<\/th><th>Investment Focus<\/th><th>Strategic Purpose<\/th><\/tr><\/thead><tbody><tr><td><strong>Lilly Lebanon API<\/strong><\/td><td>New process designs and advanced manufacturing technologies<\/td><td>Future active pharmaceutical ingredient (API) production site supporting Lilly&#8217;s expanding small molecule and biologic portfolio<\/td><\/tr><tr><td><strong>Lilly Lebanon Advanced Therapies<\/strong><\/td><td>Dedicated genetic medicine manufacturing facility (opening May 6, 2026)<\/td><td>First-of-its-kind facility supporting both clinical and commercial production of genetic medicines across full development spectrum<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-capital-commitment-timeline\">Capital Commitment Timeline<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>2020\u20132026<\/strong>: Total Indiana investment exceeds <strong>USD 21 billion<\/strong><\/li>\n\n\n\n<li><strong>Additional 2026 Commitment<\/strong>: <strong>USD 4.5 billion<\/strong> across Lebanon sites<\/li>\n\n\n\n<li><strong>Facility Launch<\/strong>: <strong>Lilly Lebanon Advanced Therapies<\/strong> opens today (May 6, 2026)<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-advanced-therapies-manufacturing-capabilities\">Advanced Therapies Manufacturing Capabilities<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Technology Platform<\/strong>: Full spectrum of <strong>genetic medicine modalities<\/strong> from research-stage development through large-scale commercial supply<\/li>\n\n\n\n<li><strong>Therapeutic Focus<\/strong>: Medicines that <strong>target disease at the genetic level<\/strong>, representing the next frontier in precision medicine<\/li>\n\n\n\n<li><strong>Production Scope<\/strong>: Integrated <strong>clinical and commercial manufacturing<\/strong> capabilities under one roof, accelerating development timelines<\/li>\n\n\n\n<li><strong>Innovation Integration<\/strong>: Incorporates cutting-edge process designs and technologies to support complex genetic medicine manufacturing requirements<\/li>\n<\/ul>\n\n\n\n<p>This dedicated genetic medicine facility positions Lilly at the forefront of the rapidly evolving <strong>advanced therapies landscape<\/strong>, where manufacturing complexity and regulatory requirements demand specialized infrastructure and expertise.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-economic-amp-strategic-implications\">Economic &amp; Strategic Implications<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Indiana Economic Impact<\/strong>: The <strong>$21+ billion investment<\/strong> represents one of the largest corporate capital commitments in Indiana history, creating thousands of high-skilled manufacturing jobs<\/li>\n\n\n\n<li><strong>Supply Chain Resilience<\/strong>: Vertical integration of API and advanced therapy manufacturing enhances Lilly&#8217;s supply chain security and reduces dependency on external contract manufacturers<\/li>\n\n\n\n<li><strong>Pipeline Support<\/strong>: The expanded manufacturing capacity directly supports Lilly&#8217;s robust pipeline, including anticipated blockbuster launches in diabetes, obesity, Alzheimer&#8217;s disease, and now genetic medicines<\/li>\n\n\n\n<li><strong>Competitive Positioning<\/strong>: As one of the first major pharmaceutical companies to establish dedicated genetic medicine manufacturing at commercial scale, Lilly gains significant <strong>first-mover advantage<\/strong> in this emerging therapeutic class<\/li>\n<\/ul>\n\n\n\n<p>The timing of this announcement reflects Lilly&#8217;s confidence in both its <strong>near-term commercial prospects<\/strong> and <strong>long-term innovation strategy<\/strong>, with genetic medicines representing a critical growth vector beyond the company&#8217;s current metabolic and neuroscience franchises.<\/p>\n\n\n\n<p><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward-looking statements regarding capital investments, manufacturing capabilities, and pipeline development. Actual results may differ due to risks including regulatory approvals, market demand, and operational execution.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Eli Lilly and Company (NYSE: LLY) announced on May 6, 2026, an additional USD 4.5&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7],"tags":[199,911],"class_list":["post-64636","post","type-post","status-publish","format-standard","hentry","category-company","tag-eli-lilly","tag-nyse-lly"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Eli Lilly Commits Additional $4.5 Billion to Indiana Manufacturing \u2013 Genetic Medicine Facility Launches as Total Investment Exceeds $21 Billion - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Eli Lilly and Company (NYSE: LLY) announced on May 6, 2026, an additional USD 4.5 billion investment across two of its three Lebanon, Indiana sites, bringing the company&#039;s total capital expansion commitments in Indiana since 2020 to more than USD 21 billion. The investment is driven by Lilly&#039;s evolving pipeline and anticipated demand for its medicines, including next-generation genetic therapies targeting disease at the molecular level.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=64636\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Eli Lilly Commits Additional $4.5 Billion to Indiana Manufacturing \u2013 Genetic Medicine Facility Launches as Total Investment Exceeds $21 Billion\" \/>\n<meta property=\"og:description\" content=\"Eli Lilly and Company (NYSE: LLY) announced on May 6, 2026, an additional USD 4.5 billion investment across two of its three Lebanon, Indiana sites, bringing the company&#039;s total capital expansion commitments in Indiana since 2020 to more than USD 21 billion. The investment is driven by Lilly&#039;s evolving pipeline and anticipated demand for its medicines, including next-generation genetic therapies targeting disease at the molecular level.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=64636\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-05-07T06:25:24+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-07T06:25:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1894\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=64636#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=64636\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Eli Lilly Commits Additional $4.5 Billion to Indiana Manufacturing \u2013 Genetic Medicine Facility Launches as Total Investment Exceeds $21 Billion\",\"datePublished\":\"2026-05-07T06:25:24+00:00\",\"dateModified\":\"2026-05-07T06:25:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=64636\"},\"wordCount\":437,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"keywords\":[\"Eli Lilly\",\"NYSE: LLY\"],\"articleSection\":[\"Company\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=64636#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=64636\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=64636\",\"name\":\"Eli Lilly Commits Additional $4.5 Billion to Indiana Manufacturing \u2013 Genetic Medicine Facility Launches as Total Investment Exceeds $21 Billion - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"datePublished\":\"2026-05-07T06:25:24+00:00\",\"dateModified\":\"2026-05-07T06:25:25+00:00\",\"description\":\"Eli Lilly and Company (NYSE: LLY) announced on May 6, 2026, an additional USD 4.5 billion investment across two of its three Lebanon, Indiana sites, bringing the company's total capital expansion commitments in Indiana since 2020 to more than USD 21 billion. The investment is driven by Lilly's evolving pipeline and anticipated demand for its medicines, including next-generation genetic therapies targeting disease at the molecular level.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=64636#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=64636\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=64636#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Eli Lilly Commits Additional $4.5 Billion to Indiana Manufacturing \u2013 Genetic Medicine Facility Launches as Total Investment Exceeds $21 Billion\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Eli Lilly Commits Additional $4.5 Billion to Indiana Manufacturing \u2013 Genetic Medicine Facility Launches as Total Investment Exceeds $21 Billion - Insight, China&#039;s Pharmaceutical Industry","description":"Eli Lilly and Company (NYSE: LLY) announced on May 6, 2026, an additional USD 4.5 billion investment across two of its three Lebanon, Indiana sites, bringing the company's total capital expansion commitments in Indiana since 2020 to more than USD 21 billion. The investment is driven by Lilly's evolving pipeline and anticipated demand for its medicines, including next-generation genetic therapies targeting disease at the molecular level.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=64636","og_locale":"en_US","og_type":"article","og_title":"Eli Lilly Commits Additional $4.5 Billion to Indiana Manufacturing \u2013 Genetic Medicine Facility Launches as Total Investment Exceeds $21 Billion","og_description":"Eli Lilly and Company (NYSE: LLY) announced on May 6, 2026, an additional USD 4.5 billion investment across two of its three Lebanon, Indiana sites, bringing the company's total capital expansion commitments in Indiana since 2020 to more than USD 21 billion. The investment is driven by Lilly's evolving pipeline and anticipated demand for its medicines, including next-generation genetic therapies targeting disease at the molecular level.","og_url":"https:\/\/flcube.com\/?p=64636","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-05-07T06:25:24+00:00","article_modified_time":"2026-05-07T06:25:25+00:00","og_image":[{"width":2560,"height":1894,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","type":"image\/jpeg"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=64636#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=64636"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Eli Lilly Commits Additional $4.5 Billion to Indiana Manufacturing \u2013 Genetic Medicine Facility Launches as Total Investment Exceeds $21 Billion","datePublished":"2026-05-07T06:25:24+00:00","dateModified":"2026-05-07T06:25:25+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=64636"},"wordCount":437,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"keywords":["Eli Lilly","NYSE: LLY"],"articleSection":["Company"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=64636#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=64636","url":"https:\/\/flcube.com\/?p=64636","name":"Eli Lilly Commits Additional $4.5 Billion to Indiana Manufacturing \u2013 Genetic Medicine Facility Launches as Total Investment Exceeds $21 Billion - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"datePublished":"2026-05-07T06:25:24+00:00","dateModified":"2026-05-07T06:25:25+00:00","description":"Eli Lilly and Company (NYSE: LLY) announced on May 6, 2026, an additional USD 4.5 billion investment across two of its three Lebanon, Indiana sites, bringing the company's total capital expansion commitments in Indiana since 2020 to more than USD 21 billion. The investment is driven by Lilly's evolving pipeline and anticipated demand for its medicines, including next-generation genetic therapies targeting disease at the molecular level.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=64636#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=64636"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=64636#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Eli Lilly Commits Additional $4.5 Billion to Indiana Manufacturing \u2013 Genetic Medicine Facility Launches as Total Investment Exceeds $21 Billion"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/64636","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=64636"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/64636\/revisions"}],"predecessor-version":[{"id":64637,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/64636\/revisions\/64637"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=64636"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=64636"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=64636"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}